The reaction to our startup was hot at ‘MWC 4YFN LA 2019’. ‘Directive (CEO Jung Ji-won, Lee Yun-jung), a team belonging to the early start-up package of Daejeon Innovation Center, was the only Korean team to be finalized in the pitching session.
In addition, more than 20 local US investors visited the Daejeon Innovation Center’s booth to meet with Dr. Fab (CEO Kim Geun-bae), who develops a patient monitoring system, to discuss the investment possibilities.
The meeting with global investors and companies in Silicon Valley was also completed. Part of the Dream Venture Star program, Billix participated in the BIO Investor Forum, conducted investment attraction IR and partnered with pharmaceutical companies and CROs.
The Bioinvestment Forum, hosted by the US Biotechnology Innovation Organization, is a conference that attracts investments from biotech investors and biotech listed companies worldwide.
The startup, which is developing anti-inflammatory drugs, has also met with members of the Korean-American Association of Korean Biopharmaceuticals (KASBP), which has helped expand the global network.
TEEware (CEO Noh Kwak), a blockchain-based security software start-up, met with Kiana (US location data analysis company) and Zeus (US electronic payment company) to expand their business.
Lim Jong-tae, Director of the Center, said, “This initiative is a strategic program designed to connect the detailed needs of startups to the US with practical results.” “The participating startups will understand the market trends and build a global competitiveness based on this network. “I hope to be a chance to improve.”